Science Explorer Interactive view Map
Company · Durham · United States

Mycovia Pharmaceuticals (United States)

Research works
22
▲ 130% vs 2013–17
Citations
1k
47.0 per fractional work
Top-10% rate
17.0%
record average 16.5%
Open access
37%
world 28%

Not ranked overall: Mycovia Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.79× its world share, 0 worksAgricultural and Bio…Immunology and Microbiology: 16.87× its world share, 1 worksImmunology and Micro…Neuroscience: 2.33× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.57× its world share, 0 worksPharmacology, Toxico…Engineering: 0.75× its world share, 0 worksEngineeringMedicine: 3.27× its world share, 3 worksMedicineworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 16.9×. Every wedge is a field page.

Which keywords describe research at Mycovia Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Fungal Pathogens, Endophytic Fungi, Cancer Therapy, Phylogenetic Analysis, Genomic Characterization, Plant Pathogenesis, Antifungal Therapy and Antioxidant Activity.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 18 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Fungal Pathogens5▲ 123×5 topics
  2. Endophytic Fungi3▲ 119×2 topics
  3. Cancer Therapy3▲ 20×4 topics
  4. Phylogenetic Analysis3▲ 33×2 topics
  5. Genomic Characterization2▲ 73×1 topic
  6. Plant Pathogenesis2▲ 153×1 topic
  7. Antifungal Therapy2▲ 91×3 topics
  8. Antioxidant Activity2▲ 16×2 topics
  9. Epidemiology2▲ 2.1×5 topics
  10. Immunomodulating Compounds2▲ 203×1 topic
  11. Medicinal Mushrooms2▲ 203×1 topic
  12. Polysaccharides2▲ 106×2 topics
  13. Immunocompromised Patients1▲ 90×2 topics
  14. Candidiasis1▲ 116×1 topic
  15. Gene Expression1▲ 9.5×3 topics
  16. Invasive Fungal Infections1▲ 145×1 topic
  17. Genomics1▲ 13×2 topics
  18. Yeast1▲ 112×2 topics

Which research topics does Mycovia Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Antifungal resistance and susceptibility, Reproductive tract infections research, Building Energy and Comfort Optimization and Fungal Infections and Studies.

  1. 1 Antifungal resistance and susceptibility Infectious Diseases 1 works
  2. 2 Reproductive tract infections research Microbiology 1 works
  3. 3 Building Energy and Comfort Optimization Building and Construction 0 works
  4. 4 Fungal Infections and Studies Epidemiology 0 works
  5. 5 Liver Disease and Transplantation Hepatology 0 works
  6. 6 Pharmacological Effects and Toxicity Studies Pediatrics, Perinatology and Child Health 0 works
  7. 7 Electrolyte and hormonal disorders Pulmonary and Respiratory Medicine 0 works
  8. 8 Animal Nutrition and Physiology Animal Science and Zoology 0 works
  9. 9 Cardiac electrophysiology and arrhythmias Cardiology and Cardiovascular Medicine 0 works
  10. 10 Reproductive Health and Contraception Public Health, Environmental and Occupational Health 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available37.4%not open62.6%

World: 28% of research is openly available.

with international co-authors13.0%domestic only87.0%

World: 19% is written across borders.

How has Mycovia Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 130% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Durham

All research institutions in Durham

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.